# FDA Inspection 1118683 - Cdymax (India) Pharma Private Limited - January 31, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/cdymax-india-pharma-private-limited/3a3ad1e2-c6a9-4a52-b05c-c0b407517416/
Source feed: FDA_Inspections

> FDA Inspection 1118683 for Cdymax (India) Pharma Private Limited on January 31, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1118683
- Company Name: Cdymax (India) Pharma Private Limited
- Inspection Date: 2020-01-31
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1271325 - 2025-04-25](https://www.globalkeysolutions.net/api/records/fda_inspections/cdymax-india-pharma-private-limited/d3543f6d-9844-437c-956e-153850c2887d/)
- [FDA Inspection 1271325 - 2025-04-25](https://www.globalkeysolutions.net/api/records/fda_inspections/cdymax-india-pharma-private-limited/a643d37d-6f70-40f5-a91d-a549b5742e4b/)
- [FDA Inspection 940635 - 2015-08-14](https://www.globalkeysolutions.net/api/records/fda_inspections/cdymax-india-pharma-private-limited/299dda63-de76-484d-8a38-1a1c2498818e/)

Company: https://www.globalkeysolutions.net/companies/cdymax-india-pharma-private-limited/51bc8d84-9900-43c0-8e1c-9d2bd08b0ac4

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c